Cannvas MedTech (CSE:MTEC), a leading business technology company within the cannabis space, is pleased to announce that Michael Bluestein of CC Corporate Counsel Professional Corporation (“Corporate Counsel”) has been engaged to support and enhance the Company’s strategic partnership efforts, corporate governance directives and general legal requirements.

“Michael will provide strategic counsel to our organization and will be a key resource in our efforts to build Cannvas into a leading technology company in the cannabis health services sector,” said Shawn Moniz, chief executive officer of Cannvas. “As a founding partner at Corporate Counsel, he provides senior counsel on a diverse range of issues to private and public corporations and has a deep understanding of the legal landscape in the Canadian technology industry. We will also benefit from his extensive expertise in corporate governance and compliance, having recently completed our listing on the Canadian Stock Exchange.”


Michael is a senior corporate and securities lawyer at Corporate Counsel with more than 10 years of experience working with public companies. His strengths include driving for results, strategic thinking and superior client service. Michael’s goal is to provide clients with practical solutions to problems while being cognizant of turn-around time and budget.

Michael has a strong background in corporate finance and has advised a wide range of clients on private equity, venture capital, M&A and other types of transactions. He has advised numerous public companies and assisted with the creation of two new stock exchanges from the ground up. Michael also has extensive experience in the technology industry from his previous counsel roles as well as from founding a tech start-up. Michael’s goal is to provide Bay Street expertise and service without the Bay Street price. He feels that clients should pay for great advice and not large overheads.

About Cannvas MedTech Inc.

Cannvas MedTech is a leading business technology company within the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.

Click here to connect with Cannvas MedTech (CSE:MTEC) for an Investors Presentation. 

Source: www.newswire.ca

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less